Lori Ferrins, Ph.D.
Affiliations: | 2015- | Northeastern University, Boston, MA, United States |
Area:
TrypanosomiasisGoogle:
"Lori Ferrins"Mean distance: 9.62 | S | N | B | C | P |
Parents
Sign in to add mentor| Jonathan Baell | grad student | 2010-2015 | Monash University |
| Michael P. Pollastri | post-doc | 2015- | Northeastern University |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| de Oliveira RG, Cruz LR, Dessoy MA, et al. (2025) Discovery and Early Optimization of 1-Indole-2-carboxamides with Anti- Activity. Journal of Medicinal Chemistry |
| Toynton A, Ferrins L, Newson HL, et al. (2025) Heterocyclic core modifications in trypanosomacidal 2-[(phenylheteroaryl)ethyl]ureas. Rsc Medicinal Chemistry |
| Spaulding A, Sharma A, Giardini MA, et al. (2025) Identification of Substituted 4-Aminocinnolines as Broad-Spectrum Antiparasitic Agents. Acs Infectious Diseases |
| Ferrins L, Diaz R, Cordon-Obras C, et al. (2024) Pharmacophore Identification and Structure-Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of . Journal of Medicinal Chemistry. 67: 13985-14006 |
| Klug DM, Tse EG, Silva DG, et al. (2023) Open Source Antibiotics: Simple Diarylimidazoles Are Potent against Methicillin-Resistant . Acs Infectious Diseases |
| Ferrins L, Buskes MJ, Kapteyn MM, et al. (2023) Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes. Frontiers in Microbiology. 14: 1304196 |
| Boby ML, Fearon D, Ferla M, et al. (2023) Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors. Science (New York, N.Y.). 382: eabo7201 |
| Dichiara M, Simpson QJ, Quotadamo A, et al. (2023) Structure-Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis. Acs Infectious Diseases |
| Ferrins L, Buskes MJ, Kapteyn MM, et al. (2023) Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes. Frontiers in Microbiology. 14: 1149145 |
| Sanders BC, Pokhrel S, Labbe AD, et al. (2023) Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2. Nature Communications. 14: 1733 |